ARTICLE | Company News
Teva sales and marketing update
June 20, 2016 7:00 AM UTC
Teva recalled all “pharmacy-level” inventory of migraine drug Zecuity sumatriptan in the U.S. and suspended sales and marketing after receiving postmarketing reports of patient skin burns at the appl...